Increased circulating T-helper 22 cells in patients with dilated cardiomyopathy
Increased circulating T-helper 22 cells in patients with dilated cardiomyopathy
复制标题
DOI:
10.3892/mmr.2014.2146
复制
发表时间:
2014-07-01
影响因子:
3.4
通讯作者:
Xue, Yimin
中科院分区:
文献类型:
--
作者:
Kong, Qing;Li, Xiaomo;Xue, Yimin
Recently, the newly determined interleukin (IL)-22-producing T-helper (Th) 22 cell has been implicated to be involved in the pathogenesis of autoimmune diseases. However, its role in the pathogenesis of dilated cardiomyopathy (DCM) has yet to be elucidated. A total of 30 patients with DCM and 30 healthy controls were enrolled in the present study. The levels of Th22, Th17 and Th1 cells in the peripheral blood were analyzed by flow cytometry. Levels of plasma IL-22 and autoantibody adenine nucleotide translocator (ANT) were assessed using the ELISA. The key transcription factor of Th22, aryl hydrocarbon receptor (AHR), was assessed using quantitative polymerase chain reaction. Additionally, clinical data on the brain natriuretic peptide (BNP), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were collected. In comparison with those in the control group, significantly elevated levels of Th22, Th17 and Th1 cells were detected in patients with DCM (all P